122 related articles for article (PubMed ID: 7718270)
1. Is CA 125 actually a tumor marker for ovarian cancer?
Collazos J
Acta Oncol; 1995; 34(2):268. PubMed ID: 7718270
[No Abstract] [Full Text] [Related]
2. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.
Sevinc A; Camci C; Turk HM; Buyukberber S
Oncology; 2003; 65(1):1-6. PubMed ID: 12837976
[TBL] [Abstract][Full Text] [Related]
3. Elevated ovarian cancer marker (CA-125) in cirrhotic patients with intractable ascites.
Zamir D; Jarchovsky J; Singer C; Weiner P
J Clin Gastroenterol; 1998 Sep; 27(2):154-5. PubMed ID: 9754780
[No Abstract] [Full Text] [Related]
4. Limitations to the use of the CA-125 antigen level in ovarian cancer.
Markman M
Curr Oncol Rep; 2003 Jul; 5(4):263-4. PubMed ID: 12781066
[No Abstract] [Full Text] [Related]
5. Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer.
Harnett P; Kerridge IH; Jordens CF; Hobbs K; Mason C; Morrell BM
Med J Aust; 2012 Apr; 196(7):440-1. PubMed ID: 22509867
[No Abstract] [Full Text] [Related]
6. Soluble interleukin-2 receptors and CA 125 in ovarian cancer, a longitudinal and cross-sectional study.
Burch D; Metcalfe S; Gallagher G; al-Azzawi F; Wheeler T
Eur J Gynaecol Oncol; 1994; 15(5):352-8. PubMed ID: 7828604
[No Abstract] [Full Text] [Related]
7. Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.
Vergote I; Rustin GJ; Eisenhauer EA; Kristensen GB; Pujade-Lauraine E; Parmar MK; Friedlander M; Jakobsen A; Vermorken JB
J Natl Cancer Inst; 2000 Sep; 92(18):1534-5. PubMed ID: 10995813
[No Abstract] [Full Text] [Related]
8. The clinical value of tumour markers in the management of ovarian cancer.
Rustin GJ
Ann Clin Biochem; 1996 Jul; 33 ( Pt 4)():284-9. PubMed ID: 8836386
[No Abstract] [Full Text] [Related]
9. Tumour markers in ovarian cancer.
Kehoe S; Selman T
Hosp Med; 2001 Aug; 62(8):452-3. PubMed ID: 11530581
[No Abstract] [Full Text] [Related]
10. Re: Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
Pisal N; Sindos M; Singer A
J Natl Cancer Inst; 2003 Feb; 95(4):331; author reply 331-2. PubMed ID: 12591991
[No Abstract] [Full Text] [Related]
11. Cirrhotic ascites, ovarian carcinoma, and CA-125.
Rubin J; Rockey DC
South Med J; 1999 Feb; 92(2):248-50. PubMed ID: 10071679
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice. Screening for ovarian cancer.
Clarke-Pearson DL
N Engl J Med; 2009 Jul; 361(2):170-7. PubMed ID: 19587342
[No Abstract] [Full Text] [Related]
13. A caveat for OV-Monitor (CA 125 antigen) measurement: something is improving, something is not.
Dorizzi RM; Meneghelli S; Rocca M; Ferrari A
Clin Chem Lab Med; 2006; 44(11):1386-7; author reply 1388. PubMed ID: 17087656
[No Abstract] [Full Text] [Related]
14. Origin of ovarian cancer may have implications for screening.
Tuma RS
J Natl Cancer Inst; 2010 Jan; 102(1):11-3. PubMed ID: 20023201
[No Abstract] [Full Text] [Related]
15. Tissue polypeptide-specific antigen and CA 125 as serum tumor markers in ovarian carcinoma.
Shabana A; Onsrud M
Tumour Biol; 1994; 15(6):361-7. PubMed ID: 7997808
[TBL] [Abstract][Full Text] [Related]
16. Can rumors cause cancer?
Jones J
J Natl Cancer Inst; 2000 Sep; 92(18):1469-71. PubMed ID: 10995800
[No Abstract] [Full Text] [Related]
17. [Huge ovarian tumor in a perimenopausal woman: a case report].
Messaoudi H; Guelzim K; Belouad M; Benlghazi A; Kouach J
Pan Afr Med J; 2021; 38():232. PubMed ID: 34046137
[TBL] [Abstract][Full Text] [Related]
18. Screening for Ovarian Cancer with CA 125 and Ultrasound Algorithm Does Not Reduce Mortality.
Ebell MH
Am Fam Physician; 2021 Oct; 104(4):422-423. PubMed ID: 34652113
[No Abstract] [Full Text] [Related]
19. An unusual abdominal cystic mass.
Montaruli E; Branchereau S
J Pediatr Hematol Oncol; 2012 Nov; 34(8):641; answer 642. PubMed ID: 23018573
[TBL] [Abstract][Full Text] [Related]
20. CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.
Bast RC
Cancer; 2010 Jun; 116(12):2850-3. PubMed ID: 20564390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
